Key result
Apixaban without aspirin reduces bleeding and hospitalizations vs VKA or aspirin regimens without increasing ischemic events.
Why the study?
Does an antithrombotic regimen including apixaban without aspirin reduce bleeding and hospitalizations in patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor?
RCT
Does an antithrombotic regimen including apixaban without aspirin reduce bleeding and hospitalizations in patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor?
In patients with atrial fibrillation and recent ACS or PCI, an apixaban-based regimen without aspirin reduces bleeding and hospitalizations compared to VKA and/or aspirin without increasing ischemic risk.
Answers are grounded in this paper and cite their sources.
Supports apixaban without aspirin to reduce bleeding and hospitalizations in AF with recent ACS/PCI; extends evidence for dual over triple antithrombotic therapy.
In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y₁₂ inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizations without significant differences in the incidence of ischemic events than regimens that included a vitamin K antagonist, aspirin, or both. (Funded by Bristol-Myers Squibb and Pfizer; AUGUSTUS ClinicalTrials.gov number, NCT02415400.).
No takes yet. Share an insight, caveat, or question.
Lópes et al. (2019) conducted an RCT in Atrial fibrillation with recent acute coronary syndrome or PCI. Apixaban without aspirin (plus P2Y12 inhibitor) vs. Regimens including a vitamin K antagonist, aspirin, or both was evaluated on Bleeding, hospitalizations, and ischemic events. Apixaban without aspirin resulted in less bleeding and fewer hospitalizations without significant differences in ischemic events vs regimens with a VKA, aspirin, or both.
Synapse has enriched 10 related papers. Consider them for comparative context: